SkylineDx to Present Data on Screening for Melanoma Patients
By Karen Roman Diagnostics company SkylineDx said it will present clinical data on the success of its Merlin test at the 21st International Congress of the Society for Melanoma Research 2024 in New Orleans. The CP-GEP Merlin test accurately stratifies...